Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "CHRO"

924 News Found

Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments
Healthcare | April 27, 2026

Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments

New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security


NIT Rourkela secures patent for rapid spice adulteration detection system
News | April 27, 2026

NIT Rourkela secures patent for rapid spice adulteration detection system

FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants


KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy
Hospitals | April 24, 2026

KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy

Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility


Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide
Hospitals | April 23, 2026

Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide

The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions


US FDA okays Merck's new once-daily HIV pill
Drug Approval | April 22, 2026

US FDA okays Merck's new once-daily HIV pill

The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir


Asahi Kasei pushes into human trials with new autoimmune drug candidate
Clinical Trials | April 22, 2026

Asahi Kasei pushes into human trials with new autoimmune drug candidate

The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp


Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%
Sustainability | April 22, 2026

Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%

Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials


Ultomiris shows strong interim results in Phase III IgA nephropathy trial
Clinical Trials | April 22, 2026

Ultomiris shows strong interim results in Phase III IgA nephropathy trial

IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys


NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine
R&D | April 21, 2026

NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine

The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways